Delivery Order SPE2DB24D2011-SPE2DB24FBNYL
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $17,092.99 and a performance period through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for Dupixent 300 mg/2 ml pen, with a ceiling value of $12,448.54 and a completion date of March 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $105,010.45, is for the supply of Dupixent 300 mg/2 ml pens. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. The delivery order, valued at $1,871.17, was issued under an Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,817.17 award is for the supply of Dupixent 300 mg/2 ml pens, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,709.46, is for the supply of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The award is not set-aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award, with an ultimate completion date of March 27, 2024, is for the supply of a specialty pharmaceutical product, Dupixent 200 mg/1.14 ml pen, at a ceiling value of $1,652.35. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Dupixent 300 mg/2 ml pens. The award is under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The delivery order has a ceiling value of $2,489.46 and is a firm fixed-price...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Dupixent 300 mg/2 ml pens. The award has a ceiling value of $6,837.84 and a completion date of February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $19,811.48 and a period of performance through March 13, 2025. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB24FBNYLDelivery Order
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution and services company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a ceiling value of $9,788.80 and a performance period through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded by DLA. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 3/13/24 |